Over the past year there were no insider purchases at Milestone Pharmaceuticals Inc.. Five insiders sold roughly $1.2 million instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. 78 investment managers listed MIST in their latest 13F filings (Q2 2026); more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Oliveto Joseph | CEO | Sell | 36,500 | $2.26 | $82K | SEC |
| Jan 28, 2026 | Bharucha David | Executive Officer | Sell | 12,245 | $1.93 | $24K | SEC |
| Jan 28, 2026 | Bharucha David | Executive Officer | Sell | 58,007 | $2.32 | $135K | SEC |
| Jan 28, 2026 | Nelson Jeffrey Edward | COO | Sell | 58,007 | $2.32 | $135K | SEC |
| Jan 28, 2026 | Nelson Jeffrey Edward | COO | Sell | 12,245 | $1.93 | $24K | SEC |
| Jan 28, 2026 | Muller Lorenz | Executive Officer | Sell | 53,566 | $2.32 | $124K | SEC |
| Jan 28, 2026 | Muller Lorenz | Executive Officer | Sell | 11,180 | $1.93 | $22K | SEC |
| Jan 28, 2026 | Hasija Amit | CFO | Sell | 12,245 | $1.93 | $24K | SEC |
| Jan 28, 2026 | Hasija Amit | CFO | Sell | 58,007 | $2.32 | $135K | SEC |
| Jan 28, 2026 | Oliveto Joseph | CEO | Sell | 34,523 | $1.93 | $67K | SEC |
| Jan 28, 2026 | Oliveto Joseph | CEO | Sell | 133,054 | $2.32 | $309K | SEC |
| Jan 9, 2026 | Oliveto Joseph | CEO | Sell | 500 | $2.25 | $1K | SEC |
| Jan 9, 2026 | Oliveto Joseph | CEO | Sell | 43,000 | $2.25 | $97K | SEC |
In the last 12 months Milestone Pharmaceuticals Inc. insiders made open-market purchases worth about $0 and sales worth about $1.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MIST was filed on 2026-04-20.
78 investment managers reported holding MIST in SEC Form 13F filings for Q2 2026.
No congressional trades in MIST were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).